Einträge von Charman, Sarah J. auf dem Publikationsserver
![]() | Eine Stufe nach oben |
Anzahl der Einträge: 3.
2026
Fuller, Amy S., Okwose, Nduka C, Charman, Sarah J., Voppel, Alban E., Stefanetti, Renae J., Groenewegen, Amy, Del Franco, Annamaria, Tafelmeier, Maria
, Preveden, Andrej, Milovancev, Aleksandra, Edwards, Duncan, Nelissen, Anne P., Barlocco, Fausto, Fornaro, Alessandra, Zamorano, Jose Luis, Milli, Massimo, Sasso, Laura, Taborchi, Giulia, Bartolini, Simone, Fatucchi, Serena, Banerjee, Prithwish, MacGowan, Guy A., Fernandez, Oscar, Bravo, Marta Jimenez-Blanco, Maier, Lars S.
, Olivotto, Iacopo, Rutten, Frans H., Mant, Jonathan, Velicki, Lazar
, Seferović, Petar M., Filipovic, Nenad und Jakovljevic, Djordje G.
(2026)
Voice recognition as an innovative method to identify and monitor heart failure – a review.
Heart Failure Reviews 31 (1).
2025
Darbà, Josep, Ascanio, Meritxell, Rodríguez, Antonio, Charman, Sarah J., Okwose, Nduka C., Stefanetti, Renae J., Groenewegen, Amy, Del Franco, Annamaria, Tafelmeier, Maria
, Preveden, Andrej, Fuller, Amy S., Bano, Fatima, Sinclair, David R., Edwards, Duncan, Nelissen, Anne P., Malitas, Petros N., Zisaki, Aikaterini, Bosnić, Zoran, Vračar, Petar, Fornaro, Alessandra, Barlocco, Fausto, Fotiadis, Dimitris, Banerjee, Prithwish, MacGowan, Guy A., Fernandez, Oscar, Zamorano, José Luis, Jimenez-Blanco Bravo, Marta, Maier, Lars S.
, Olivotto, Iacopo, Milli, Massimo, Rutten, Frans H., Mant, Jonathan, Velicki, Lazar, Seferovic, Petar M., Filipovic, Nenad und Jakovljevic, Djordje G.
(2025)
Economic Burden of Heart Failure in Europe: A Systematic Review of Costs and Cost-Effectiveness.
ESC Heart Failure 12 (6), S. 4055-4068.
2024
Velicki, Lazar, Popovic, Dejana, Okwose, Nduka C., Preveden, Andrej, Tesic, Milorad, Tafelmeier, Maria
, Charman, Sarah J., Barlocco, Fausto, MacGowan, Guy A., Seferovic, Petar M., Filipovic, Nenad, Ristic, Arsen, Olivotto, Iacopo, Maier, Lars S.
und Jakovljevic, Djordje G.
(2024)
Sacubitril/Valsartan for the Treatment of Non-Obstructive Hypertrophic Cardiomyopathy: An Open Label Randomized Controlled Trial (SILICOFCM).
European Journal of Heart Failure 26 (6), S. 1361-1368.
